drugset / Trial / NCT06438263
A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The main objective of this study is to evaluate the pharmacokinetics (PK) of rocatinlimab given as a single subcutaneous (SC) autoinjector dose compared to vial in healthy participants.
Timeline
- Start
- 2024-08-06
- Primary completion
- 2025-05-03
- Completion
- 2025-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rocatinlimab | Monoclonal antibody | — | Subcutaneous |